Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 1 regulatory subunit 3B (PPP1R3B) is a regulatory subunit that targets the serine/threonine phosphatase PP1 specifically to glycogen particles in the liver and skeletal muscle[1][2][4][5]. By directing PP1 to its key substrates—glycogen synthase and glycogen phosphorylase—PPP1R3B stimulates glycogen synthesis and limits glycogen breakdown, thereby playing a critical role in maintaining glucose and energy homeostasis in response to nutritional and hormonal cues[2][4][5]. Genetic variants affecting PPP1R3B expression are associated with altered hepatic glucose and lipid storage, influencing the risk of metabolic diseases such as type 2 diabetes, hepatic steatosis, and hyperinsulinemic hypoglycemia[2][4]. PPP1R3B, expressed predominantly in liver, acts as a metabolic switch between glycogen and fat storage in hepatocytes, and its activity or dysregulation has been implicated in both rare and common metabolic disorders[4][6]. There are currently no approved drugs targeting PPP1R3B directly, but it remains of interest for its central metabolic regulatory role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 3B (PPP1R3B).